阿立哌唑与利培酮治疗精神分裂症的对比观察
 |
| 第1页 |
参见附件。
摘要:目的探究阿立哌唑与利培酮治疗精神分裂症的疗效对比，为精神分裂症患者寻求最佳的治疗方式。方法选取2009年1月~2012年1月收治的100例精神分裂症患者为研究对象，按照治疗方式的不同分为阿立哌唑组与利培酮组，治疗8周后，观察两组患者症状改善情况与临床疗效。结果两组患者治疗后的PANSS评分相比治疗前P<0.05；治疗的第2、4、8周，阿立哌唑组的不良反应均低于利培酮组，比较P<0.05；差异具有统计学意义。两组临床效果比较上无显著差异。结论阿立哌唑与利培酮治疗精神分裂症均有良好的疗效，但阿立哌唑的不良反应更少，安全性更高，临床用药时可根据患者的具体情况进行选择用药。
关键词:阿立哌唑；利培酮；精神分裂症
abstract :objective to explore the vertical pp azole compared with risperidone treatment the curative effect of schizophrenia, seek the best treatment for patients with schizophrenia. Methods from January 2009 to January 2012, 100 cases of schizophrenia patients as the research object, according to the divided into the treatment set pp azole group and risperidone group, 8 weeks after treatment, the symptoms in both groups was observed and the clinical curative effect. Results two groups of patients after treatment of PANSS score than before treatment (P < 0.05; Treatment of 2, 4, 8 weeks, o set pp adverse reactions of group were lower than that of risperidone group, comparing P < 0 ......
您现在查看是摘要介绍页，详见PDF附件。